Medicare Advantage (MA) plans often advertise dental, vision, and hearing benefits as significant advantages over traditional Medicare (TM). However, a recent study published in JAMA Network Open by researchers from Mass General Brigham reveals that the reality does not match the promise (Cai, et al., 2025).1 Despite offering these supplemental benefits, MA beneficiaries do not typically receive more of these services than their TM counterparts, and out-of-pocket (OOP) spending remains comparable for most services. Researchers analyzed data from 76,557 Medicare beneficiaries between 2017 and 2021, sourced from the Medical Expenditure Panel Survey (MEPS) and the Medicare Current Beneficiary Survey (MCBS). The study’s goal was to evaluate whether MA plans deliver on their advertised advantages. How well were the supplemental services utilized? The study revealed that only 54.2% of MA beneficiaries were aware of their dental coverage, and only 54.3% knew about vision coverage. And the study found that MA enrollees were no more likely to receive eye examinations, hearing aids, or eyeglasses than TM enrollees. Cost-sharing structures and lack of awareness about benefits probably contribute to underutilization. How did out-of-pocket costs compare? While out-of-pocket (OOP) costs were slightly lower for MA beneficiaries, the differences were modest:
Nationally, MA plans spent $3.9 billion annually on vision, dental, and durable medical equipment. Beneficiaries themselves paid $9.2 billion OOP, while other private insurers covered an additional $2.8 billion. The study highlights a troubling inequality. MA plans receive $37.2 billion more annually from taxpayers than TM plans would have cost for the same beneficiaries. This funding is partly intended to enhance access to supplemental benefits. However, the findings suggest that these additional funds do not translate into significantly greater service utilization or reduced costs for beneficiaries. Dr. Christopher Cai, the study's lead author, points out that this raises questions about whether the increased taxpayer investment in MA is justified. "Our findings add to the evidence that this increased cost is not justified," Cai said. The findings challenge one of MA’s key selling points: better access to supplemental services. Senior author Dr. Lisa Simon emphasized that older adults and individuals with disabilities deserve more from Medicare, especially when choosing a MA plan based on advertised benefits. So the question is, "Why are MA benefits so poorly utilized?" That question was clearly answered by researchers from Mass General Brigham after they investigated and found significant deficiencies in dental coverage provided by Medicare advantage plans (Simon, Vugicic, and Nasseh, 2024, December 26).2 Despite Medicare Advantage being a privatized alternative to traditional Medicare, offering additional benefits like dental coverage, only a small fraction of plans meet quality standards. The findings, published in JAMA, raise concerns about the accessibility and adequacy of dental care for millions of beneficiaries (Simon, Vujicic, and Nasseh, 2024).3 The researchers found that only 8.4% of Medicare Advantage plans offered a dental benefit that met quality standards comparable to employer-sponsored plans, such as:
Many plans feature complex benefit structures, such as high co-pays, coverage caps, or limited inclusion of services like fillings and crowns. These complexities can make it difficult for consumers to evaluate plans during open enrollment. Regulatory oversight is obviously lacking. The researchers point out the need for stricter regulations to ensure that low-quality dental plans are not offered, thereby protecting consumers. Regulations could also mandate greater transparency, making it easier for beneficiaries to understand the scope and quality of dental benefits. With the current lack of adequate regulation, MA plans are reminiscent of bygone times when manufacturers could write ads for snake oil that promised the moon, but only delivered disappointment. References 1. Cai, C. L., Iyengar, S., Woolhandler, S., Himmelstein, D. U., Kannan, K., and Simon, L. (2025). Use and Costs of Supplemental Benefits in Medicare Advantage, 2017-2021. JAMA Network Open, 8(1):e2454699. Retrieved from https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2829183 2. Simon, L., Vugicic, M., and Nasseh, K. (2024, December 26). Investigation Uncovers Poor Quality of Dental Coverage under Medicare Advantage. Mass General Brigham, Retrieved from https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/investigation-uncovers-poor-quality-of-dental-coverage-under-medicare-advantage 3. Simon, L, Vujicic, M, and Nasseh, K. (2024). Availability of Dental Benefits Within Medicare Advantage Plans by Enrollment and County. JAMA, Retrieved from https://pubmed.ncbi.nlm.nih.gov/39724145/
2 Comments
Posie Jarreau
11/13/2025 11:35:45 am
After 2 plus years having been diagnosed with Lymphocytic Colitis, I feel relieved to find a place I can receive help. I thank you for your interest in this illness. I bought your book around August, 2023 but since I felt my GI doctor was going to get me well I am only now reaching out for more help. My doctor insisted that a change in diet would not change things. I will be 80 years old in January 2026. My life has changed drastically. Even though I have accepted my condition, I do have many very difficult moments. I wonder if a treatment may have caused my illness. In July of 2023 I was sent to a pelvic floor therapist where she used biofeedback on me and after my third treatment I developed severe diarrhea. By August 2023 I was diagnosed with Microscopic LC. Do you feel that a treatment such as this with one time when the electrical device was set too high and I was calling the Therapist to come lower it, she said she could not hear her little bell and she did not come in when I called? It seems no one can answer this question. It has entered my thoughts many times since this is the time when my Lymphatic Colitis began. I was given many different medications that did not help. Since January 2025 I have been on Entyvio shots every other Friday. A few days seem OK but I have mostly bad days than good. I have an appointment scheduled with a Nutritionist on November 26, 2025 as I feel it is time for me to get very serious with change of diet. Thank you so much for any comments you can make.
Reply
Wayne
11/13/2025 12:05:15 pm
There is no published evidence of electrical overstimulation causing the development of lymphocytic colitis, nor is there any logical reason why it would. Probably, what happened was that your LC was developing, but not yet symptomatic, and the electrical stimulation was sufficient to cause symptoms to begin.
Reply
Leave a Reply. |
AuthorWayne Persky Archives
December 2025
Categories |
RSS Feed